Chronic kidney disease is a worldwide health problem. The �Fistula First Breakthrough Initiative� helped increase the use of arteriovenous fistulas (AVFs), as AVFs have the lowest rates of infection, thrombosis, and steal syndrome and the best potential flow volumes during dialysis.